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1A SEMIPARAMETRIC APPROACH FOR
THE COVARIATE SPECIFIC ROC CURVE
WITH SURVIVAL OUTCOME
Xiao Song and Xiao-Hua Zhou
University of Georgia,
Department of Biostatistics, University of Washington,
and Northwest HSR&D Center of Excellence, VA Puget Sound Health Care System
Abstract: The receiver operating characteristic (ROC) curve has been extended to survival data
recently, including the nonparametric approach by Heagerty, Lumley and Pepe (2000) and the
semiparametric approach by Heagerty and Zheng (2005) using standard survival analysis tech-
niques based on two different time-dependent ROC curve definitions. However, both approaches
cannot adjust for the effect of covariates on the accuracy of the biomarker. To account for the co-
variate effect, we propose semiparametric models for covariate specific ROC curves corresponding
to the two time-dependent ROC curve definitions, respectively. We show that the estimators are
consistent and converge to Gaussian processes. In the case of no covariates, the estimators are
demonstrated to be more efficient than the Heagerty-Lumley-Pepe estimator and the Heagerty-
Zheng estimator via simulation studies. In addition, the estimators can be easily extended to
other survival models. We apply these estimators to an HIV dataset.
Key words and phrases: Location model, Proportional hazards model, Receiver operating characteristic
curve, Survival analysis.
1. Introduction
The receiver operating characteristic (ROC) curve is a popular tool to assess the effect of biomarkers
in screening and predicting disease. A biomarker can be a single variable or a composite score of several
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variables. Exciting promises in identification of biomarkers using high dimensional microarray data have
been recently demonstrated (Pepe, Longton, Anderson and Schummer, 2003). The ROC curve can be
viewed as a plot of the true versus false positive rates among all possible thresholds for classifying disease
and nondisease patients. One appealing property of the ROC curve is that it provides a common scale
for comparing the accuracy of biomarkers, which may be measured in different units, in distinguishing two
states of a binary outcome. Various approaches have been proposed for estimating the ROC curve (Zhou,
Obuchowski and McClish, 2002, Chapters 4 and 5; Pepe, 2003, Chapter 5). When covariates have an impact
on the accuracy of a biomarker, it is important to account for the covariate effects in applying the ROC
curve (Zhou, Obuchowski and McClish, 2002, Chapter 8; Pepe, 2003, Chapter 6), which lead to the ROC
curve adjusted for specific covariate effects, namely the covariate-specific ROC curve.
Recently, the ROC curve has been extended to survival time to evaluate the accuracy of biomarkers
in classifying subjects based on time to an event, such as time to progression to a disease. Heagerty and
Zheng (2005) give a systematic review of such time-dependent ROC curves. The true positive rate (TPR)
and false positive rate (FTR) of a ROC curve can be extended in two different ways for survival time: the
TPR is generalized to incident TPR and cumulative TPR, and the FPR is generalized to dynamic FPR and
static FPR. Heagerty, Lumley and Pepe (2000) proposed a nonparametric approach for the time-dependent
ROC curve based on the incident TPR and the dynamic FPR, using the Kaplan-Meier estimator of the
survival distribution and the empirical distribution estimator of the biomarker. Heagerty and Zheng (2005)
took a semiparametric approach for the time-dependent ROC curve based on the cumulative TPR and
the dynamic FPR, using a proportional hazards model for a linear combination of several variables as the
biomarker. Both the Heagerty-Lumley-Pepe and Heagerty-Zheng approaches can be used to evaluate and
compare biomarkers in classifying subjects based on their survival times (Heagerty and Zheng, 2005); the
former is useful in distinguishing subjects failing by a given time and those failing after this time, and the
latter is useful in distinguishing subjects failing at a given time and those failing after this time. However,
these two approaches do not adjust for the effect of covariates on the accuracy of a biomarker; adjusting for
the covariate effect may be important in assessing the accuracy of a biomarker. An example is the HIVNET
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012, a randomized clinical trial to compare nevirapine (200mg at labor onset and 2mg/kg for babies within
72 hours of birth) and zidovudine (600mg at labor onset and 300mg every 3 hours until delivery, and 4mg/kg
orally twice daily for babies for 7 days) for prevention of mother-to-child transmission of HIV-1 (Jackson et
al., 1996). HIV-1 infected pregnant women in Kampala, Uganda, were recruited between November 1997
and April 1999, with 313 assigned nevirapine and 313 zidovudine. Two possible biomarkers, the maternal
HIV-1 RNA and CD4 count, were measured at baseline. It would be interesting to evaluate the capacities of
the biomarkers in classification of the babies based on their time to HIV infection or death, which may be
different for the two treatment groups. Thus it may be important to adjust for the treatment in constructing
the ROC curves.
In this paper, we consider two types of time-dependent ROC curves for survival data adjusted for
covariates. They correspond to the ROC curves used by Heagerty, Lumley and Pepe (2000) and Heagerty
and Zheng (2005), respectively, in the case of no covariates. We allow the biomaker to be composed of several
variables as considered by Heagerty and Zheng (2005). Moreover, covariates other than those variables
contained in the biomarker can be adjusted in constructing the ROC curves. We assume that the survival
time depends on the biomarker and covariates through a proportional hazards model and that the biomarker
depends on the covariates through a semiparametric location model. Semiparametric estimators are proposed
for the time-dependent ROC curves. We show that these estimators are consistent and converge to Gaussian
processes. This approach can be easily extended to other survival models as discussed in Section 7.
The paper is organized as follows. We define the covariate specific time-dependent ROC curves in
Section 2 and derive the estimators in Section 3. The asymptotic properties are given in Section 4. We
assess the finite sample performance of the estimators by simulation in Section 5 and apply the method to
the HIV data described above in Section 6. The paper concludes with discussions in Section 7.
2. Definition
Let Y be a biomarker, T be the survival time, C be the censoring time, and X be a vector of covariates
that may affect T . The observed survival data are V = min(T,C) and ∆ = I(T ≤ C), where I(·) is the
indicator function. Suppose that larger values of Y are associated with great hazards to events; otherwise,
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Y can be recoded if necessary to achieve this. The ROC curve for survival time is defined based on TPR and
FPR by analogy to that for a binary outcome. To define the covariate specific time-dependent ROC curve,
we first define the conditional TPR and FPR given the covariate X. Specifically, for X = x, the cumulative
TPR, the incident TPR and the (dynamic) FPR at time t are defined, respectively, as
TPRC(y; t, x) = P (Y > y|T ≤ t,X = x),
TPRI(y; t, x) = P (Y > y|T = t,X = x),
and
FPR(y; t, x) = P (Y > y|T > t,X = x).
Then we define the cumulative ROC curve as
ROCC(v; t, x) = TPRC
{
FPR−1(v; t, x); t, x
}
,
and the incident ROC curve as
ROCI(v; t, x) = TPRI
{
FPR−1(v; t, x); t, x
}
.
Both the cumulative and the incident time-dependent ROC curves can be used to evaluate and compare
the accuracy of biomarkers in classifying subjects based on their survival times adjusting for covariates;
the former is useful in distinguishing subjects failing by a given time and those failing after this time,
while the latter is useful in distinguishing subjects failing at a given time and those failing after this time.
The Heagerty-Lumley-Pepe approach deals with the cumulative ROC curve without covariates, and the
Heagerty-Zheng approach estimates the incident ROC curve without covariates.
3. Estimation
With some simple algebra, TPRC , TPRI and FPR can be written as
TPRC(y; t;x) =
∫∞
y
{1− S(t|u, x)} dP (Y ≤ u|X = x)∫∞
−∞ {1− S(t|u, x)} dP (Y ≤ u|X = x)
, (3.1)
TPRI(y; t, x) =
∫∞
y
f(t|u, x)dP (Y ≤ u|X = x)∫∞
−∞ f(t|u, x)dP (Y ≤ u|X = x)
, (3.2)
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and
FPR(y; t;x) =
∫∞
y
S(t|u, x)dP (Y ≤ u|X = x)∫∞
−∞ S(t|u, x)dP (Y ≤ u|X = x)
, (3.3)
where S(t|y, x) = P (T ≥ t|Y = y,X = x) is the conditional survival distribution function given Y = y and
X = x, and f(t|y, x) = −dS(t|y, x)/dt is the corresponding conditional survival density.
To estimate these quantities, we assume a proportional hazard model for the survival time,
λ(t|Y,X) = λ0(t) exp
(
β0Y + γT0 X
)
, (3.4)
and a semiparametric location model for the biomarker,
P (Y ≤ y|X) = H(y − αT0X), (3.5)
where λ0(·) is an unspecified baseline hazard function, and H(·) is an unspecified distribution function.
Suppose that the observed data {(Vi,∆i, Yi, Xi) : i = 1, . . . , n} are independent and identically distributed
samples from (V,∆, Y,X).
The estimator of α0, say αˆ, can be obtained by solving
n∑
i=1
(Yi − αTXi)Xi = 0, (3.6)
and H(y) can be estimated by
Hˆ(y, αˆ) = n−1
n∑
i=1
I
(
Yi − αˆTXi ≤ y
)
.
Under model (3.4), we can write the survival function S(t|y, x) = exp{−Λ0(t) exp (βy + γTx)}, where
Λ0(t) =
∫ t
0
λ0(u)du is the cumulative baseline hazard function. Let Ni(u) = I(Vi ≤ u,∆i = 1) be the
counting process and Ri(u) = I (Vi ≥ u) be the at risk process. An estimator of S(t|y, x) is
Sˆ(t|y, x) = exp
{
−Λˆ0(t) exp
(
βˆy + γˆTx
)}
,
where (βˆ, γˆ) is the maximum partial likelihood estimator of (β0, γ0), which solves the partial score equation
at time L,
n∑
i=1
∫ L
0
{
(Yi, XTi )
T −
∑n
j=1Ri(u)(Yi, X
T
i )
T exp
{
βYi + γTXi
}∑n
j=1Ri(u) exp {βYi + γTXi}
}
dNi(u) = 0,
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and Λˆ0(t) is the Breslow estimator of Λ0(t) given by
Λˆ0(t) =
n∑
i=1
∫ t
0
dNi(u)∑n
j=1Ri(u) exp
{
βˆYi + γˆTXi
} .
The density f(t|y, x) can be estimated by fˆ(t|y, x) = −∂Sˆ(t|y, x)/∂t. Substituting the estimators of S(t|u, x),
f(t|u, x) and P (Y ≤ u|X = x) into (3.1)–(3.3), we obtain estimators of TPRC , TPRI and FPR, which are
given by
T̂PRC(y; t, x) =
∫∞
y
{
1− Sˆ(t|u, x)
}
dHˆ(u− αˆx, αˆ)∫∞
−∞
{
1− Sˆ(t|u, x)
}
dHˆ(u− αˆx, αˆ)
=
∑n
i=1
[
1− Sˆ {t|Yi − αˆ(Xi − x), x}
]
I {Yi − αˆ(Xi − x) ≥ y}∑n
i=1
[
1− Sˆ {t|Yi − αˆ(Xi − x), x}
] , (3.7)
T̂PRI(y; t, x) =
∫∞
y
fˆ(t|u, x)Sˆ(t|u, x)dHˆ(u− αˆx, αˆ)∫∞
−∞ fˆ(t|u, x)Sˆ(t|u, x)dHˆ(u− αˆx, αˆ)
=
∑n
i=1 exp
{
βˆYi − αˆ(Xi − x)
}
Sˆ {t|Yi − αˆ(Xi − x), x} I {Yi − αˆ(Xi − x) ≥ y}∑n
i=1 exp
{
βˆYi − αˆ(Xi − x)
}
Sˆ {t|Yi − αˆ(Xi − x), x}
,
(3.8)
and
F̂PR(y; t;x) =
∫∞
y
Sˆ(t|u, x)dHˆ(u− αˆx, αˆ)∫∞
−∞ Sˆ(t|u, x)dHˆ(u− αˆx, αˆ)
=
∑n
i=1 Sˆ {t|Yi − αˆ(Xi − x), x} I {Yi − αˆ(Xi − x) ≥ y}∑n
i=1 Sˆ {t|Yi − αˆ(Xi − x), x}
, (3.9)
respectively. Thus the estimators of ROCC(v; t) and ROCI(v; t) are
R̂OCC(v; t, x) = T̂PRC
{
F̂PR
−1
(v; t, x); t, x
}
,
and
R̂OCI(v; t, x) = T̂PRI
{
F̂PR
−1
(v; t, x); t, x
}
,
respectively. Note that both estimators can be used in the case of no covariate by setting αˆ in (3.7)–(3.9) to
be 0. For valid estimation, t should be less than the maximum follow-up time.
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4. Asymptotic Properties
Let Y and X be the supports of Y and X, respectively. We derive the asymptotic properties of the
estimators under some regularity conditions given in Appendix A. We first show the following lemmas.
Lemma 1 Given x ∈ X , n1/2
{
Hˆ(y − αˆTx, αˆ)−H(y − αT0 x)
}
, as a process of y, converges to a mean zero
Gaussian process on Y with the covariance given in Appendix B.
Lemma 2 Given (x, t) ∈ X × [0, L], n1/2
{
Sˆ(t|·, x)− S(t|·, x)
}
converges to a mean zero Gaussian process
on Y with the covariance given in Appendix B.
The proofs are sketched in Appendix B.
Using these lemmas, we show in Appendix C the following theorem.
Theorem 1 Given (x, t) ∈ X × [0, L],
n1/2
{
F̂PR(.; t, x)− FPR(.; t, x)
}
,
n1/2
{
T̂PRC(.; t, x)− TPRC(.; t, x)
}
,
and
n1/2
{
T̂PRI(.; t, x)− TPRI(.; t, x)
}
converge to mean zero Gaussian processes on Y with the covariances given in Appendix C.
The asymptotic properties of the ROC curves then follow from Theorem 1 by the functional delta method
(van der Vaart and Wellner, 2000, Chapter 3.9).
Theorem 2 Given (x, t) ∈ X × [0, L],
n1/2
{
R̂OCC(.; t, x)− ROCC(.; t, x)
}
and
n1/2
{
R̂OCI(.; t, x)− ROCI(.; t, x)
}
converge to mean zero Gaussian processes on [p, q] with the covariances given in Appendix C, where p and q
are defined in condition H in Appendix C.
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The covariance formulas for these processes contain density functions. Smoothing techniques are needed
to compute the standard errors based on these formulas. Alternatively, we may compute the standard errors
and confidence bands using the bootstrap method.
5. Simulation Studies
To assess the performance of the estimators, we conduct simulations under the following scenarios. We
first consider the simple case when there is no covariate. The hazard of failure depends on the biomarker only
through the proportional hazards model. The true regression coefficient is β0 = 1, and the baseline hazard
is a constant 0.1. The censoring distribution is the exponential distribution with mean 30 truncated at 20,
leading to a censoring rate of 34%. For estimation of the cumulative ROC curve, we compare the estimator
R̂OCC with the Heagerty-Lumley-Pepe estimator; for estimation of the incident ROC curve, we compare the
estimator R̂OCI with the Heagerty-Zheng estimator. The smoothing bandwidth for the Heagerty-Lumley-
Pepe approach is taken to be n−1/3/3. We consider the ROC curves at t = 5 with the true curves shown in
Figure 1(a). For the sample size n = 300 and 600, we generate 500 simulated data sets. The ROC curves
are estimated at v = 0.1, 0.3, 0.5, 0.7, 0.9. For all these estimators, the standard errors are computed by the
bootstrap method using 100 resampled data sets. The 95% Wald confidence intervals are constructed using
the bootstrap standard errors. The results are shown in Tables 1 and 2 for ROCC and for ROCI , respectively.
All estimators show negligible bias. The bootstrap standard errors track the empirical standard deviations
well, and the coverage probabilities are close to the nominal level for all the semiparametric estimators, but
may be a little below the nominal level for the nonparametric Heagerty-Lumley-Pepe estimator when v is close
to 0 or 1. The semiparametric estimator R̂OCC has smaller bias and is more efficient than the nonparametric
Heagerty-Lumley-Pepe estimator as we expected. Interestingly, R̂OCI also achieves smaller bias and better
efficiency than the Heagerty-Zheng estimator, although they are both semiparametric estimators.
Next we consider the case when the hazard of failure depends on the marker Y and a single covariate X
through the proportional hazards model. The true regression coefficients are β0 = 1 and γ0 = 0.5, and the
baseline hazard is a constant 0.1. The covariate X is generated from a normal distribution with mean 1 and
variance 1, and the marker Y is generated from a conditional normal distribution with mean X and variance
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1. The censoring time is generated in the same way as described above with the censoring rate being 33%.
We estimate the ROC curves for X = 0, 1, 2 at t = 5 and v = 0.1, 0.3, 0.5, 0.7, 0.9 with the true curves shown
in Figure 1(b). The Heagerty-Lumley-Pepe estimator and Heagerty-Zheng estimator are not applicable in
this case. We use R̂OCC to estimate the cumulative ROC curve and R̂OCI to estimate the incident ROC
curve. The results are shown in Tables 3 and 4. Both estimators work well under this case.
6. Application
We apply these approaches to the HIVNET 012 data described in Section 1. It is thought that the
maternal HIV-1 RNA and CD4 count may contain information in predicting the time to HIV infection or
death of a child. The indicator for the treament, X = I(treatment = nevirapine), might have impact on the
capacity of the two biomarkers. Here the survival time is the time to HIV infection or death of a child. There
were 89 events in the nevirapine group, and 60 events in the zidovudine group. We estimate the cumulative
and incident ROC curves for the two biomarkers adjusted for the treatment using the proposed estimators.
To ensure the validity of these estimators, we check the proportional hazards assumption using the
method in Therneau and Grambsch (Chapter 6.2, 2000). We consider two proportional hazards model, one
including log transformed maternal HIV-1 RNA and X, and the other including log transformed CD4 count
and X; use of log transformations on HIV-1 RNA and CD4 count is standard in the medical literature.
There is no evidence against the proportional hazards assumption.
To compare the accuracy of the two biomarkers in distinguishing subjects failing by a given time t and
those failing after t, we estimate the cumulative ROC curves using the estimator R̂OCC for X = 0, 1 at
t = 0.5, 1, 1.5 and 2 years. The 95% Wald confidence intervals are computed by the bootstrap method using
100 resampled data sets. The results are shown in Figure 2. Considering the FPR to be less than 15%,
HIV-1 RNA seems to be a better biomarker than CD4 count for subjects taking nevirapine, but CD4 count
seems to be a better marker in the zidovudine group.
To compare the accuracy of the two biomarkers in distinguishing subjects failing at t and those failing
after t, we estimate the incident ROC curves using the estimator R̂OCI adjusting for X = 0, 1 with the
same choices of time t. The results are presented in Figure 3. In contrast to their effects of classification of
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failures by or after these times, CD4 count seems to be a better biomarker than HIV-1 RNA for subjects
taking nevirapine, but HIV-1 RNA seems to be a better marker in the zidovudine group when the FPR is
less than 15%.
7. Discussion
We have proposed semiparametric estimators for the cumulative ROC curve and the incident ROC
curve for survival data that may adjust for covariate effects. The proposed estimators are consistent and
converge to Gaussian processes. These approaches work well in the case of moderate sample sizes. In the
case of no covariate, these estimators are more efficient than the Heagerty-Lumley-Pepe method and the
Heagerty-Zheng method, respectively.
Cai, Pepe, Lumley, Zheng and Jenny (2006) estimated the time-dependent ROC curve based on the
cumulative TPR and static FPR, assuming standard binary regression models for the cumulative TPR
and the static FPR and a proportional hazards model for the censored distribution. Loosely speaking,
Cai et al.’s approach assumes models for the conditional distributions P (Y |T,X) and P (T |X), while our
approach assumes models for the conditional distributions P (T |Y,X) and P (Y |X), where P (A|B) denotes
the conditional distribution of A given B. Our approach provides an alternative way to estimate the time-
dependent ROC curve adjusted for covariates. Compared to Cai et al.’s approach, our approach has the
advantage of simple computation; the estimating equations (3.4) and (3.6) are much easier to solve than the
estimating equations (3.3) and (3.4) in Cai, Pepe, Lumley, Zheng and Jenny (2006).
We assume a standard proportional hazards model for the hazard given the biomarker and covariates,
and a semiparametic location model for the conditional distribution of the biomarker given the covariates.
The consistency of the proposed estimators depend on the correct specification of these models. However, the
approach can be easily adapted to more flexible models. For example, we can replace other survival models,
such as the stratified proportional hazards model, the accelerated failure time model and transformation
models, as long as we can obtain consistent estimators for the survival distributions. It is well known that
the nonparametric transformation survival model is a flexible survival model, including the proportional
hazards model and the accelerated failure time model as special cases. The semiparametric location model
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is used only for estimating the conditional distribution P (Y ≤ y|X = x). We can remove this assumption
and estimate P (Y ≤ y|X = x) by kernel smoothing method when the number of covariates is small and the
sample size is relatively large, since the kernel method may not work well otherwise.
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Appendix A: Regularity Conditions
Let η = (β, γT )T , ηˆ = (βˆ, γˆT )T , z = (y, xT )T , Z = (Y,XT )T , W = (V,∆, Z), and
Qbi (η;Wi, s) = Ri(s)Z⊗bi exp
(
ηTZi
)
, b = 0, 1, 2,
where a⊗b = 1, a, aaT for b = 0, 1, 2 respectively. Suppose η0 = (β0, γT0 )
T is an internal point in a compact
set and write N (η0) as a neighborhood of η0.
To derive the asymptotic properties, we assume the following regularity conditions.
A. T and C are independent given Z;
B. P (V ≥ L) > 0 for a constant L > 0;
C. E(ZTZ) <∞, E
{
supη∈N (η0) Z
TZ exp
(
ηTZi
)}
<∞;
D. Σ (η0) =
∫ τ
0
{
EQ2(η0;Wi,s)
EQ0(η0;Wi,s)
− EQ21(η0;Wi,s)
EQ20(η0;Wi,s)
}
EdN(s) is positive definite;
E. For (y, x) ∈ Y × X , S(t|y, x) is an absolutely continuous function for t ∈ [0, L];
F. H(u) is bounded and has bounded first- and second-order derivativesH ′(u) andH ′′(u)for u ∈ (−∞,+∞);
G. Γ = E(XXT ) is positive definite;
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H. The conditional densities
f1(y; t, x) = −dTPRC(y; t, x)
dy
=
{1− S(t|y, x)}H ′(y − αT0 x)∫∞
−∞ {1− S(t|u, x)} dP (Y ≤ u|X = x)
,
f∗1 (y; t, x) = −
dTPRI(y; t, x)
dy
=
{f(t|y, x)S(t|y, x)}H ′(y − αT0 x)∫∞
−∞ f(t|u, x)S(t|u, x)dP (Y ≤ u|X = x)
,
and
f0(y; t, x) = −dFPR(y; t, x)
dy
=
S(t|y, x)H ′(y − αT0 x)∫∞
−∞ S(t|u, x)dP (Y ≤ u|X = x)
exist, and f0(y; t, x) is positive for y ∈
[
F (−1)(p)− ε, F (−1)(q) + ε] for some constants p and q, 0 <
p < q < 1, and ε > 0.
Appendix B: Proofs of Lemma 1 and Lemma 2
Proof of Lemma 1. Note that the semiparametric location model is equivalent to
Y = αT0X + e,
where e has the distribution function H(·). Under Conditions C and F, the least square estimator αˆ is
consistent and asymptotically normal with
n1/2 (αˆ− α0) = n−1/2
n∑
i=1
Γ−1
(
XiYi −XiXTi α0
)
+ op(1). (B.1)
Let N (α0) be a compact neighborhood of α0. Letting B(α) = EH
{
y + αT (X − x)− αT0X
}
, by the func-
tional central limit theorem,
n1/2
[
Hˆ(y − αTx, α)−B(α)
]
converges to a mean zero Gaussian process on (y,α) ∈ Y ×N (α0). It follows from the equicontinuity of the
foregoing process and the consistency of αˆ that
sup
y∈Y
∣∣∣n1/2 [Hˆ(y − αˆTx, αˆ)−B(αˆ)]− n1/2 [Hˆ(y − αT0 x, α0)−H {y − αT0 x}]∣∣∣ = op(1).
This implies that
n1/2
{
Hˆ(y − αˆTx, αˆ)−H(y − αT0 x)
}
= n1/2
{
Hˆ(y − αT0 x, α0)−H(y − αT0 x)
}
+n1/2
{
B(αˆ)−H(y − αT0 x)
}
+ op(1) (B.2)
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uniformly for y ∈ Y. Under condition F, the second term in (B.2) can be written by a Taylor series expansion
as
H ′(y − αT0 x) {E(X)− x}T n−1/2 (αˆ− α0) + op(1)
uniformly for y ∈ Y. This, together with (B.1), implies that
n1/2
{
Hˆ(y − αˆTx, αˆ)−H(y − αT0 x)
}
= n−1/2
n∑
i=1
h(α0, y, x;Zi) + op(1),
where
h(α0, y, x;Zi) =
[{
I
(
Yi − αT0Xi ≤ y − αT0 x
)−H(y − αT0 x)}
+H ′(y − αT0 x) {E(X)− x}T Γ−1
(
XiYi −XiXTi α0
)]
.
Thus n1/2
{
Hˆ(y − αˆTx, αˆ)−H(y − αT0 x)
}
converges to a Gaussian process H(y;x) with covariance
cov {H(y1;x),H(y2;x)} = cov {h(α0, y1, x;Zi), h(α0, y2, x;Zi)} .
Proof of Lemma 2. Under Conditions A–E, n1/2(ηˆ−η) is normal, and n1/2{Λˆ0(t)−Λ0(t)} converges to
a Gaussian process (Andersen & Gill, 1982). Thus n−1/2{Sˆ(t|·, x)− S(t|·, x)}, as a functional differentiable
with respect to (η,Λ0), converges to a Gaussian process S(·; t, x) on Y by the functional delta method.
Specifically, by the functional Taylor expansion, with some algebra, we can show that
n1/2
{
Sˆ(t|y, x)− S(t|y, x)
}
= n−1/2
n∑
i=1
ξ(η0, t, y, x,Wi) + op(1),
where
ξ(η0, t, y, x,Wi) = S(t|y, x) exp
{
ηT0 z
}(
δ(t, η0,Wi)
−

∫ t
0
EQ1 (η0;Wi, s)EdN(s)
E2Q0 (η0;Wi, s)
− Λ0(t)
 y
x

 g(η0,Wi)
 ,
δ(t, η0,Wi) =
∫ t
0
dNi(s)EQ0 (η0;Wi, s)−Ri(s) exp
{
ηT0 Zi
}
EdN(s)
E2Q0 (η0;Wi, s)
,
and
g(η;Wi) = Σ−1 (η0)
∫ L
0
{
Zi − EQ1 (η0;Wi, s)
EQ0 (η0;Wi, s)
}{
dNi(s)− Q0i (η0;Wi, s)
EQ0 (η0;Wi, s)
EdN(s)
}
.
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Thus cov{S(y1; t, x),S(y2; t, x)} = cov{ξ(η0, t, y1, x,Wi), ξ(η0, t, y2, x,Wi)}.
Appendix C: Proofs of Theorem 1 and Theorem 2
Proof of Theorem 1. Since FPR is differentiable as a composite functional of (η,Λ0,H, α), by the
functional delta method, n1/2
{
F̂PR(·; t, x)− FPR(·; t, x)
}
converges to a Gaussian process F(·; t, x) with
mean zero on Y. To derive the asymptotic covariance, using the functional Taylor expansion, we have
n1/2
{
F̂PR(y; t, x)− FPR(y; t, x)
}
= n1/2
[∫ ∞
−∞
S(t|u, x)dH(u− αT0 x)
]−1
×
[∫ ∞
y
{
Sˆ(t|u, x)− S(t|u, x)
}
dH(u− αT0 x)
+
∫ ∞
y
S(t|u, x)d
{
Hˆ(u− αˆTx, αˆ)−H(u− αTx)
}]
−n1/2
[∫ ∞
−∞
S(t|u, x)dH(u− αT0 x)
]−2 ∫ ∞
y
S(t|u, x)dH(u− αT0 x)
×
[∫ ∞
−∞
{
Sˆ(t|u, x)− S(t|u, x)
}
dH(u− αT0 x)
+
∫ ∞
−∞
S(t|u, x)d
{
Hˆ(u− αˆTx, αˆ)−H(u− αT0 x)
}]
+op(1)
= n−1/2
n∑
i=1
$i(y; t, x) + op(1),
where
$i(y; t, x) =
[∫ ∞
−∞
S(t|u, x)dH(u− αT0 x)
]−1
×
[∫ ∞
y
ξ(η0, t, u, x, Zi)dH(u− αT0 x) +
∫ ∞
y
S(t|u, x)dh(α0, u, x;Zi)
]
−
[∫ ∞
−∞
S(t|u, x)dH(u− αT0 x)
]−2 ∫ ∞
y
S(t|u, x)dH(u− αT0 x)
×
[∫ ∞
−∞
ξ(η0, t, u, x, Zi)dH(u− αT0 x) +
∫ ∞
−∞
S(t|u, x)dh(α0, u, x;Zi)
]
.
Thus cov{F(y1; t, x),F(y2; t, x)} =cov{$i(y1; t, x), $i(y2; t, x)}.
Similarly, we can show that n1/2{T̂PRC(·; t, x)−TPRC(·; t, x)} and n1/2{T̂PRI(·; t, x)−TPRI(·; t, x)}
converge to Gaussian processes TC(·; t, x) and TI(·; t, x) on Y, respectively, with mean zero,
cov{TC(y1; t, x), TC(y2; t, x)} = cov {ζi(y1; t, x), ζi(y2; t, x)} ,
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and
cov{TI(y1; t, x), TI(y2; t, x)} = cov{ζ∗i (y1; t, x), ζ∗i (y2; t, x)},
where
ζi(y; t, x) =
[∫ ∞
−∞
{1− S(t|u, x)} dH(u− αT0 x)
]−1
×
[∫ ∞
y
−ξ(η0, t, u, x, Zi)dH(u− αT0 x) +
∫ ∞
y
{1− S(t|u, x)} dh(α0, u, x;Zi)
]
−
[∫ ∞
−∞
{1− S(t|u, x)} dH(u− αT0 x)
]−2 ∫ ∞
y
{1− S(t|u, x)} dH(u− αT0 x)
×
[
−
∫ ∞
−∞
ξ(η0, t, u, x, Zi)dH(u− αT0 x) +
∫ ∞
−∞
{1− S(t|u, x)} dh(α0, u, x;Zi)
]
,
and
ζ∗i (y; t, x) =
[∫ ∞
−∞
S(t|u, x)dH(u− αT0 x)
]−1
×
[∫ ∞
y
u exp (β0u)S(t|u, x)dH(u− αT0 x)g(η;Zi) +
∫ ∞
y
ξ(η0, t, u, x, Zi)dH(u− αT0 x)
+
∫ ∞
y
S(t|u, x)dh(α0, u, x;Zi)
]
−
[∫ ∞
−∞
S(t|u, x)dH(u− αT0 x)
]−2 ∫ ∞
y
S(t|u, x)dH(y − αT0 x)
×
[∫ ∞
−∞
u exp (β0u)S(t|u, x)dH(u− αT0 x)g(η;Zi) +
∫ ∞
−∞
ξ(η0, t, u, x, Zi)dH(u− αT0 x)
−
∫ ∞
−∞
S(t|u, x)dh(α0, u, x;Zi)
]
.
Proof of Theorem 2. Since ROCC(v; t, x) is a composite functional of S(t|y, x) and H(αˆ, y− αˆx), under
Assumption H, by the functional delta method, n1/2{R̂OCC(·; t;x)−ROCC(·; t, x)} converges to a Gaussian
process GC(·; t, x) for on [p, q]. Specifically, using the functional Taylor expansion, we have
n1/2
{
R̂OCC(v; t, x)− ROCC(v; t, x)
}
= n1/2
n∑
i=1
ϕi(v; t, x) + op(1),
where
ϕi(v; t, x) = ζi
{
FPR−1(v; t, x)
}− f1 {FPR−1(v; t, x); t, x} $i {FPR−1(v; t, x); t, x}
f0
{
FPR−1(v; t, x); t, x
} .
Thus cov{GC(v1; t, x),GC(v2; t, x)} = cov{ϕi(v1; t, x), ϕi(v2; t, x)}.
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Similarly, we can show that n1/2
{
R̂OCI(·; t;x)− ROCI(·; t, x)
}
converges to a Gaussian process GI(·; t, x)
on [p, q] with mean zero and covariance cov{GI(v1; t, x),GI(v2; t, x)} = cov{ϕ∗i (v1; t, x), ϕ∗i (v2; t, x)}, where
ϕ∗i (v; t, x) = n
1/2
n∑
i=1
ζ∗i
{
FPR−1(v; t, x)
}− f∗1 {FPR−1(v; t, x); t, x} $i {FPR−1(v; t, x); t, x}
f0
{
FPR−1(v; t, x); t, x
} .
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Table 1. Simulation results for the cumulative ROC in the case of no covariate. HLP, Heagerty-Lumley-Pepe
estimator; B, bias; SD, empirical standard deviation across simulated data sets; SE, average of estimated
standard errors; CP, coverage probability of the 95% confidence interval.
n = 300 n = 600
v ROCC Method B SD SE CP B SD SE CP
0.1 0.4841 R̂OCC −0.0019 0.0397 0.0386 0.934 −0.0027 0.0254 0.0272 0.958
HLP −0.0362 0.0746 0.0753 0.904 −0.0385 0.0555 0.0536 0.864
0.3 0.7362 R̂OCC −0.0019 0.0292 0.0284 0.926 −0.0021 0.0190 0.0201 0.964
HLP −0.0219 0.0565 0.0584 0.920 −0.0222 0.0415 0.0408 0.928
0.5 0.8677 R̂OCC −0.0020 0.0186 0.0181 0.932 −0.0014 0.0121 0.0128 0.958
HLP −0.0122 0.0432 0.0416 0.938 −0.0122 0.0288 0.0293 0.940
0.7 0.9463 R̂OCC −0.0014 0.0094 0.0092 0.936 −0.0010 0.0061 0.0065 0.964
HLP −0.0058 0.0272 0.0260 0.916 −0.0052 0.0176 0.0182 0.960
0.9 0.9903 R̂OCC −0.0007 0.0024 0.0024 0.958 −0.0004 0.0016 0.0017 0.956
HLP −0.0020 0.0102 0.0097 0.880 −0.0021 0.0074 0.0071 0.924
Table 2. Simulation results for the incident ROC in the case of no covariate. HZ, Heagery-Zheng estimator;
B, bias; SD, empirical standard deviation across simulated data sets; SE, average of estimated standard
errors; CP, coverage probability of the 95% confidence interval.
n = 300 n = 600
v ROCI Method B SD SE CP B SD SE CP
0.1 0.3042 R̂OCI −0.0010 0.0200 0.0196 0.932 −0.0007 0.0133 0.0136 0.958
HZ −0.0082 0.0273 0.0275 0.932 −0.0045 0.0196 0.0193 0.936
0.3 0.6088 R̂OCI −0.0020 0.0240 0.0237 0.948 −0.0017 0.0162 0.0166 0.946
HZ −0.0050 0.0285 0.0284 0.934 −0.0034 0.0197 0.0199 0.956
0.5 0.7935 R̂OCI −0.0023 0.0192 0.0189 0.944 −0.0013 0.0130 0.0132 0.960
HZ −0.0027 0.0218 0.0212 0.932 −0.0016 0.0146 0.0149 0.950
0.7 0.9129 R̂OCI −0.0017 0.0114 0.0112 0.944 −0.0010 0.0076 0.0079 0.962
HZ −0.0024 0.0128 0.0123 0.934 −0.0013 0.0082 0.0086 0.970
0.9 0.9837 R̂OCI −0.0011 0.0034 0.0034 0.942 −0.0006 0.0023 0.0023 0.960
HZ −0.0013 0.0037 0.0036 0.944 −0.0007 0.0024 0.0025 0.960
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Table 3. Simulation results for the cumulative ROC in the case of a single covariate. B, bias; SD, empiri-
cal standard deviation across simulated data sets; SE, average of estimated standard errors; CP, coverage
probability of the 95% confidence interval.
n = 300 n = 600
X v ROCC B SD SE CP B SD SE CP
0 0.1 0.4217 −0.0026 0.0407 0.0398 0.936 −0.0014 0.0268 0.0280 0.954
0.3 0.7001 −0.0019 0.0325 0.0322 0.944 −0.0003 0.0219 0.0226 0.956
0.5 0.8494 −0.0012 0.0213 0.0211 0.944 −0.0002 0.0144 0.0148 0.952
0.7 0.9391 −0.0009 0.0108 0.0109 0.952 −0.0003 0.0074 0.0076 0.950
0.9 0.9890 −0.0005 0.0027 0.0027 0.954 −0.0001 0.0018 0.0019 0.950
1 0.1 0.5091 −0.0023 0.0395 0.0391 0.952 −0.0002 0.0269 0.0275 0.958
0.3 0.7509 −0.0016 0.0281 0.0279 0.948 −0.0001 0.0193 0.0196 0.956
0.5 0.8753 −0.0011 0.0174 0.0174 0.940 −0.0003 0.0119 0.0122 0.952
0.7 0.9494 −0.0010 0.0087 0.0088 0.958 −0.0003 0.0060 0.0061 0.946
0.9 0.9908 −0.0007 0.0023 0.0023 0.948 −0.0002 0.0015 0.0016 0.960
2 0.1 0.7030 −0.0005 0.0368 0.0372 0.952 0.0005 0.0270 0.0258 0.934
0.2 0.8594 −0.0014 0.0210 0.0215 0.952 −0.0005 0.0159 0.0149 0.936
0.3 0.9315 −0.0017 0.0120 0.0122 0.966 −0.0005 0.0090 0.0084 0.932
0.5 0.9724 −0.0014 0.0059 0.0059 0.960 −0.0004 0.0043 0.0040 0.924
0.9 0.9950 −0.009 0.0017 0.0016 0.902 −0.0004 0.0011 0.0011 0.924
Table 4. Simulation results for the incident ROC in the case of a single covariate. B, bias; SD, empiri-
cal standard deviation across simulated data sets; SE, average of estimated standard errors; CP, coverage
probability of the 95% confidence interval.
n = 300 n = 600
X v ROCI B SD SE CP B SD SE CP
0 0.1 0.3408 −0.0024 0.0269 0.0271 0.942 −0.0007 0.0189 0.0187 0.956
0.3 0.6440 −0.0019 0.0280 0.0284 0.956 −0.0002 0.0199 0.0196 0.938
0.5 0.8173 −0.0011 0.0205 0.0208 0.954 0.0000 0.0145 0.0143 0.944
0.7 0.9251 −0.0008 0.0113 0.0114 0.942 −0.0002 0.0079 0.0079 0.938
0.9 0.9863 −0.0005 0.0031 0.0031 0.958 −0.0001 0.0021 0.0021 0.948
1 0.1 0.2960 −0.0019 0.0181 0.0185 0.960 −0.0003 0.0129 0.0127 0.944
0.3 0.5991 −0.0013 0.0229 0.0232 0.956 −0.0001 0.0160 0.0160 0.952
0.5 0.7863 −0.0009 0.7854 0.0187 0.954 −0.0001 0.0128 0.0129 0.950
0.7 0.9093 −0.0013 0.0111 0.0113 0.954 −0.0005 0.0078 0.0079 0.942
0.9 0.9828 −0.0011 0.0036 0.0035 0.942 −0.0004 0.0024 0.0024 0.944
2 0.1 0.2545 −0.0013 0.0150 0.0154 0.944 −0.0007 0.0104 0.0106 0.964
0.2 0.5505 −0.0033 0.0218 0.0225 0.950 −0.0016 0.0156 0.0157 0.946
0.3 0.7492 −0.0047 0.0199 0.0206 0.936 −0.0019 0.0144 0.0144 0.948
0.5 0.8877 −0.0046 0.0143 0.0143 0.936 −0.0018 0.0101 0.0100 0.938
0.9 0.9772 −0.0039 0.0061 0.0057 0.848 −0.0017 0.0038 0.0038 0.926
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Figure 1. True ROC curves at t = 5 in simulation. Solid line, cumulative ROC; dashed line, incident ROC.
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Figure 2. Estimated the cumulative ROC curves adjusted for treatment for the HIVNET 012 data. The plots
from left to right are for t = 0.5, 1.0, 1.5 and 2, respectively. Left plots, zidovudine; Right plots, nevirapine;
ROC curves for the maternal HIV-1 RNA, solid lines; ROC curves for the maternal CD4 count, dashed line;
95% confidence bands are shown with the outer curves, 95% pointwise confidence intervals are shown with
the intermediate curves, the estimates themselves are shown with the center curves.
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Figure 3. Estimated the incident ROC curves adjusted for treatment for the HIVNET 012 data. The plots
from top to bottom are for t = 0.5, 1.0, 1.5 and 2, respectively. Left plots, zidovudine; Right plots, nevirapine;
ROC curves for the maternal HIV-1 RNA, solid lines; ROC curves for the maternal CD4 count, dashed line;
95% confidence bands are shown with the outer curves, 95% pointwise confidence intervals are shown with
the intermediate curves, the estimates themselves are shown with the center curves.
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